Željko Reiner
#138,405
Most Influential Person Now
Researcher
Željko Reiner's AcademicInfluence.com Rankings
Željko Reinercomputer-science Degrees
Computer Science
#6489
World Rank
#6842
Historical Rank
Machine Learning
#2126
World Rank
#2154
Historical Rank
Artificial Intelligence
#2386
World Rank
#2427
Historical Rank
Database
#3575
World Rank
#3726
Historical Rank
Download Badge
Computer Science
Željko Reiner's Degrees
- PhD Computer Science University of Zagreb
- Masters Computer Science University of Zagreb
- Bachelors Computer Science University of Zagreb
Similar Degrees You Can Earn
Why Is Željko Reiner Influential?
(Suggest an Edit or Addition)Željko Reiner's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) (2012) (6922)
- 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2013) (6036)
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 (2010) (4824)
- [ESC/EAS Guidelines for the management of dyslipidaemias]. (2011) (3612)
- ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). (2011) (3071)
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. (2016) (1974)
- Lipoprotein(a) as a cardiovascular risk factor: current status (2010) (1466)
- Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) (2007) (1141)
- ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). (2011) (1103)
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management (2011) (1099)
- Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) (2007) (1040)
- European guidelines on cardiovascular disease prevention in clinical practice: executive summary. (2007) (965)
- European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invit (2007) (911)
- [European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)]. (2013) (876)
- European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invit (2007) (869)
- EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries (2016) (863)
- European guidelines on cardiovascular disease prevention in clinical practice: full text (2005) (840)
- The 2013 ESH/ESC guidelines for the management of arterial hypertension (2013) (805)
- Third universal definition of myocardial infarction. (2012) (751)
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention (2016) (657)
- 'Ten Commandments' from the 2016 ESC/EAS Guidelines for the management of dyslipidaemias. (2011) (596)
- Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the Europe (2010) (520)
- The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. (2008) (473)
- Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry (2019) (471)
- EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE (ENDING). FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE (2004) (412)
- The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011. (2014) (299)
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. (2011) (290)
- Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel (2017) (289)
- The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients (2008) (261)
- EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries (2010) (249)
- Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular risk factors: recommendations from the EACPR (Part II) (2012) (246)
- Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction. (2014) (246)
- Hypertriglyceridaemia and risk of coronary artery disease (2017) (236)
- Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes Mellitus: A Global Case–Control Study in 13 Countries (2013) (203)
- Statins and the COVID-19 main protease: in silico evidence on direct interaction (2020) (203)
- The Role of Nutraceuticals in Statin Intolerant Patients. (2018) (191)
- Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries. (2019) (177)
- Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries. (2019) (177)
- Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries. (2019) (177)
- Resistance and intolerance to statins. (2014) (168)
- Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey. (2016) (165)
- Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel# (2017) (151)
- Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease. (2005) (151)
- Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). (2018) (147)
- Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial. (2017) (145)
- Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: the PERCRO-DOC survey. (2010) (133)
- Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology. (2011) (129)
- Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology. (2015) (129)
- 2010 Focused Update of ESC Guidelines on device therapy in heart failure (2010) (128)
- Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update. (2013) (113)
- The Therapeutic Potential of Anthocyanins: Current Approaches Based on Their Molecular Mechanism of Action (2020) (110)
- Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score". (2018) (100)
- Population-level changes to promote cardiovascular health (2012) (99)
- Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology (2015) (98)
- Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey (2011) (98)
- Dyslipidemias in the Prevention of Cardiovascular Disease: Risks and Causality (2012) (96)
- Management of patients with familial hypercholesterolaemia (2015) (95)
- Combined therapy in the treatment of dyslipidemia (2010) (94)
- Adverse effects of statins - myths and reality. (2015) (92)
- The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease. (2019) (88)
- Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration. (2016) (85)
- The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential (2019) (84)
- [2016 ESC/EAS Guidelines for the Management of Dyslipidaemias]. (2016) (83)
- The gender gap in risk factor control: Effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology. (2016) (83)
- Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey (2015) (81)
- Statins in the primary prevention of cardiovascular disease (2013) (78)
- Safety of red yeast rice supplementation: A systematic review and meta‐analysis of randomized controlled trials (2019) (77)
- Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia. (2016) (74)
- A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy. (2015) (72)
- Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) (2021) (68)
- Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and meta-analysis of randomized placebo-controlled trials. (2016) (64)
- Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: findings from the EUROASPIRE III survey. (2013) (64)
- Cost-effectiveness of optimizing prevention in patients with coronary heart disease: the EUROASPIRE III health economics project. (2012) (61)
- Effect of orlistat on plasma lipids and body weight: A systematic review and meta‐analysis of 33 randomized controlled trials (2017) (60)
- Public perceptions of cardiovascular risk factors in Croatia: the PERCRO survey. (2010) (60)
- Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES (2019) (56)
- Effects of Rice Policosanol on Serum Lipoproteins, Homocysteine, Fibrinogen and C-Reactive Protein in Hypercholesterolaemic Patients (2005) (54)
- Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study) (2006) (54)
- Prevalence of statin intolerance: a meta-analysis (2022) (53)
- Effects of statin therapy on augmentation index as a measure of arterial stiffness: A systematic review and meta-analysis. (2016) (52)
- Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force. (2021) (52)
- The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP). (2020) (50)
- Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic (2020) (50)
- Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors (2017) (47)
- Passive smoking and smoking cessation among patients with coronary heart disease across Europe: results from the EUROASPIRE III survey. (2014) (45)
- Management of overweight and obese patients with coronary heart disease across Europe (2010) (45)
- Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries (2016) (44)
- OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP). (2021) (43)
- Impact of Statin Therapy on Plasma Uric Acid Concentrations: A Systematic Review and Meta-Analysis (2016) (43)
- Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries. (2020) (43)
- Risk stratification in cardiovascular disease primary prevention – scoring systems, novel markers, and imaging techniques (2012) (41)
- PCSK9 inhibitors – past, present and future (2015) (38)
- The perception and knowledge of cardiovascular risk factors among medical students (2012) (37)
- Readiness for smoking cessation in coronary heart disease patients across Europe: Results from the EUROASPIRE III survey (2015) (37)
- Educational level and risk profile and risk control in patients with coronary heart disease (2016) (35)
- Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study (2022) (34)
- Nutraceutical support in heart failure: a position paper of the International Lipid Expert Panel (ILEP) (2020) (33)
- Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials (2018) (33)
- Dietary supplements, vitamins and minerals as potential interventions against viruses: Perspectives for COVID-19. (2021) (33)
- Continental-Mediterranean and rural-urban differences in cardiovascular risk factors in Croatian population (2011) (32)
- Impact of statin therapy on plasma levels of plasminogen activator inhibitor-1 (2016) (32)
- How to improve cardiovascular diseases prevention in Europe? (2009) (32)
- PCSK9 inhibitors in clinical practice: Expectations and reality. (2018) (31)
- Cardiovascular disease (CVD) risk factors in older adults - Perception and reality. (2015) (30)
- Symptomatic hypomagnesemia associated with gentamicin therapy. (1990) (29)
- Primary Prevention of Cardiovascular Disease with Statins in the Elderly (2014) (29)
- Characterization of a monoclonal antibody that binds equally to all apolipoprotein and lipoprotein forms of human plasma apolipoprotein B. I. Specificity and binding studies. (1986) (29)
- Prevention of cardiovascular disease guided by total risk estimations − challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy (2012) (29)
- Prevalence and types of persistent dyslipidemia in patients treated with statins (2013) (28)
- Mental disorders, treatment response, mortality and serum cholesterol: a new holistic look at old data. (2007) (28)
- Impact of Early Evidence of Atherosclerotic Changes on Early Treatment in Children With Familial Hypercholesterolemia (2014) (28)
- Comorbidity, multimorbidity and personalized psychosomatic medicine: epigenetics rolling on the horizon. (2010) (27)
- Effect of l-dopa on growth hormone, glucose, insulin, and cortisol response in obese subjects. (2009) (26)
- The burden of hyperlipidaemia and diabetes in cardiovascular diseases (2007) (26)
- Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer (2020) (26)
- Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study (2018) (26)
- Medicinal plants and bioactive natural compounds as inhibitors of HMG‐CoA reductase: A literature review (2020) (25)
- The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion. (2019) (25)
- The effects of combined magnesium and zinc supplementation on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease (2020) (24)
- PCSK9 and infection: A potentially useful or dangerous association? (2018) (24)
- Improvement of endothelial function by pitavastatin: a meta-analysis (2018) (24)
- The effects of grape seed extract on glycemic control, serum lipoproteins, inflammation, and body weight: A systematic review and meta‐analysis of randomized controlled trials (2019) (24)
- Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service. (2005) (24)
- Effects of resistant starch on glycemic control, serum lipoproteins and systemic inflammation in patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled clinical trials (2020) (24)
- Atherosclerosis of retinal arteries in men: role of serum lipoproteins and apoproteins. (2004) (24)
- New ESC/EAS Guidelines for the management of dyslipidaemias − any controversies behind the consensus? (2011) (23)
- Variants of ESR1, APOE, LPL and IL-6 loci in young healthy subjects: association with lipid status and obesity (2009) (23)
- Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries. (2021) (23)
- Regular exercise behaviour and intention and symptoms of anxiety and depression in coronary heart disease patients across Europe: Results from the EUROASPIRE III survey (2017) (23)
- SURF – SUrvey of Risk Factor management: first report of an international audit (2014) (22)
- Molecular and Biological Functions of Quercetin as a Natural Solution for Cardiovascular Disease Prevention and Treatment (2020) (22)
- The Effects of Nano-curcumin on Metabolic Status in Patients With Diabetes on Hemodialysis, a Randomized, Double Blind, Placebo-controlled Trial. (2020) (22)
- Differences in risk factors for coronary heart disease in patients from continental and Mediterranean regions of Croatia (2008) (22)
- The year in cardiology 2018: prevention (2019) (22)
- Determinants of plasma viscosity in primary hyperlipoproteinemias (1995) (22)
- Genistein as a regulator of signaling pathways and microRNAs in different types of cancers (2021) (22)
- Renal transplantation in patients with Balkan endemic nephropathy. (2007) (21)
- The effects of saffron (Crocus sativus L.) on mental health parameters and C-reactive protein: A meta-analysis of randomized clinical trials. (2020) (21)
- Th-W47:2 Atherosclerosis — A paradox of Eastern European countries (2006) (20)
- Lifestyle and risk factor management in people at high cardiovascular risk from Bulgaria, Croatia, Poland, Romania and the United Kingdom who participated in both the EUROASPIRE III and IV primary care surveys (2016) (20)
- A review of gene‐ and cell‐based therapies for familial hypercholesterolemia (2019) (20)
- The effects of spirulina on glycemic control and serum lipoproteins in patients with metabolic syndrome and related disorders: A systematic review and meta‐analysis of randomized controlled trials (2019) (20)
- Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey. (2018) (20)
- [Concomitant use of statins and cytochrome P 450 inhibitors in Croatia]. (2005) (20)
- Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP) (2022) (20)
- Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP) (2022) (20)
- Diabetic dyslipidemia or ‘diabetes lipidus’? (2011) (19)
- Fetal toxicity associated with statins: A systematic review and meta-analysis. (2021) (19)
- Cytokines and growth factors in mostly atherosclerotic patients on hemodialysis determined by biochip array technology (2007) (19)
- [New information on the pathophysiology of atherosclerosis]. (2001) (18)
- Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials. (2018) (18)
- Raloxifene Lowers Plasma Lipoprotein(a) Concentrations: a Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials (2017) (18)
- Changes in Serum Lipid and Lipoprotein Levels in Postmenopausal Patients with Node-Positive Breast Cancer Treated with Tamoxifen (1998) (18)
- The effects of L-carnitine supplementation on indicators of inflammation and oxidative stress: a systematic review and meta-analysis of randomized controlled trials (2020) (18)
- Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases (2022) (18)
- Macrophage: A key therapeutic target in atherosclerosis? (2019) (17)
- Advantages and Disadvantages of Inclisiran: A Small Interfering Ribonucleic Acid Molecule Targeting PCSK9—A Narrative Review (2022) (17)
- Mutation detection in Croatian patients with Familial Hypercholesterolemia (2013) (17)
- Interaction Between Coronavirus S-Protein and Human ACE2: Hints for Exploring Efficient Therapeutic Targets to Treat COVID-19 (2020) (17)
- Pulse wave velocity as a measure of arterial stiffness in patients with familial hypercholesterolemia: a systematic review and meta-analysis (2019) (17)
- Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2022) (17)
- A Systematic Review and Meta-Analysis of Controlled Trials on the Effects of Statin and Fibrate Therapies on Plasma Homocysteine Levels. (2016) (17)
- Impact of Statin Therapy on Plasma Vitamin D Levels: A Systematic Review and Meta-Analysis. (2017) (17)
- Effects of statins on preeclampsia: A systematic review. (2020) (16)
- The Therapeutic Potential of Nanoparticles to Reduce Inflammation in Atherosclerosis (2019) (16)
- [Less salt--more health. Croatian action on salt and health (CRASH)]. (2016) (16)
- Are Elevated Serum Triglycerides Really a Risk Factor for Coronary Artery Disease? (2015) (16)
- Percentage low-density lipoprotein-cholesterol response to a given statin dose is not fixed across the pre-treatment range: Real world evidence from clinical practice: Data from the ESC-EORP EUROASPIRE V Study (2020) (16)
- The effects of omega-3 fatty acids from flaxseed oil on genetic and metabolic profiles in patients with gestational diabetes mellitus: a randomized, double-blind, placebo-controlled trial. (2020) (15)
- The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy via the Modulation of Inflammatory Milieu (2019) (15)
- 32 TRIGLYCERIDE-RICH LIPOPROTEINS AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN PATIENTS AT HIGH RISK OF CARDIOVASCULAR DISEASE: EVIDENCE AND GUIDANCE FOR MANAGEMENT (2011) (15)
- Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial. (2020) (15)
- Can Lp(a) Lowering Against Background Statin Therapy Really Reduce Cardiovascular Risk? (2019) (14)
- The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials. (2020) (14)
- Prediction of recurrent event in patients with coronary heart disease: the EUROASPIRE Risk Model. (2020) (14)
- Quercetin as a Novel Therapeutic Approach for Lymphoma (2021) (14)
- Statin Use in COVID-19 Hospitalized Patients and Outcomes: A Retrospective Study (2022) (14)
- Preclinical atherosclerosis and cardiovascular events: Do we have a consensus about the role of preclinical atherosclerosis in the prediction of cardiovascular events? (2022) (13)
- Inflammatory Biomarkers for Cardiovascular Risk Stratification in Familial Hypercholesterolemia. (2020) (13)
- Butyrylcholinesterase activity and plasma lipids in dexamethasone treated rats. (2005) (13)
- Statin therapy in athletes and patients performing regular intense exercise - Position Paper from the International Lipid Expert Panel (ILEP). (2020) (13)
- Mitochondrial myopathy associated with a novel 5522G>A mutation in the mitochondrial tRNATrp gene (2012) (13)
- Treatment of children with homozygous familial hypercholesterolaemia (2018) (12)
- A comparison of European and US guidelines for familial hypercholesterolaemia (2015) (12)
- The effects of cortisol, 11-epicortisol, and lysine vasopressin on DNA and RNA synthesis in isolated human adrenocorticotropic hormone-secreting pituitary tumor cells (1990) (12)
- Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy (2018) (12)
- [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?]. (2010) (12)
- HRVATSKE SMJERNICE ZA PREHRANU OSOBA STARIJE DOBI, DIO II – KLINIČKA PREHRANA (2011) (12)
- Lipoprotein(a) predicts progression of carotid artery intima-media thickening in patients with type 2 diabetes: A four-year follow-up (2010) (11)
- Novel Experimental Agents for the Treatment of Hypercholesterolemia (2021) (11)
- P705Step by step diagnosis and management of statin intolerance: position paper from an international lipid expert panel (2019) (11)
- Effects of lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene variants on metabolic syndrome traits. (2013) (11)
- Guidelines, position papers and critical reviews: differences and similarities (2013) (11)
- Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia (2021) (11)
- [Three-year-old boy--a homozygote for familiar hypercholesterolemia]. (2007) (11)
- Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial. (2021) (11)
- ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology. (2018) (10)
- Methotrexate for Cardiovascular Risk Reduction: The Right Choice? (2020) (10)
- A systematic review and meta-analysis: The effects of probiotic supplementation on metabolic profile in patients with neurological disorders. (2020) (10)
- Effects of whey protein on glycemic control and serum lipoproteins in patients with metabolic syndrome and related conditions: a systematic review and meta-analysis of randomized controlled clinical trials (2020) (10)
- Clinical Study on the Effect of Simvastatin on Paraoxonase Activity (2007) (10)
- Endogenous steroid sex hormones and atherosclerosis of retinal arteries in men. (2009) (10)
- Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection (2021) (10)
- Rice policosanol does not have any effects on blood coagulation factors in hypercholesterolemic patients. (2007) (10)
- Guidelines on CVD prevention: confusing or complementary? (2013) (9)
- SMJERNICE ZA PREVENCIJU, PREPOZNAVANJE I LIJEČENJE NEDOSTATKA VITAMINA D U ODRASLIH (2016) (9)
- Effects of flaxseed oil supplementation on biomarkers of inflammation and oxidative stress in patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials. (2020) (9)
- The role of statins in lung cancer (2021) (9)
- Thigh abscess as an extension of psoas abscess: the first manifestation of perforated appendiceal adenocarcinoma: case report (2015) (9)
- GUIDELINES FOR THE PREVENTION, DETECTION AND THERAPY OF VITAMIN D DEFICIENCY IN ADULTS. (2016) (9)
- Risk factors for microvascular atherosclerotic changes in patients with type 2 diabetes mellitus. (2013) (9)
- Flaxseed Supplementation Reduces Plasma Lipoprotein(a) Levels: A Meta-Analysis. (2019) (9)
- The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2021) (8)
- Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials (2018) (8)
- Statin Therapy in Post-Operative Atrial Fibrillation: Focus on the Anti-Inflammatory Effects (2021) (8)
- Similarities and differences between European and United States guidelines for the management of dyslipidaemias. (2015) (8)
- Deletion polymorphism of the angiotensin I-converting enzyme gene in elderly patients with coronary heart disease. (2001) (8)
- EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from twenty four European countries (2016) (8)
- Resveratrol and cardiac fibrosis prevention and treatment. (2021) (8)
- Association of Serum PCSK9 Levels with Antibiotic Resistance and Severity of Disease in Patients with Bacterial Infections Admitted to Intensive Care Units (2019) (7)
- Dialyzer reprocessing with peroxyacetic acid as sole cleansing and sterilizing agent. (1997) (7)
- The effects of catechin on endothelial function: A systematic review and meta-analysis of randomized controlled trials (2020) (7)
- Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health within the general population: Recommendations from the EACPR (Part I) Short title: Exercise and PA characteristics in primary prevention (2012) (7)
- Interaction of genetic risk factors confers increased risk for metabolic syndrome: the role of peroxisome proliferator-activated receptor γ. (2014) (7)
- Clinical Study on the Effect of Simvastatin on Butyrylcholinesterase Activity (2005) (7)
- Alirocumab: targeting PCSK9 to treat hypercholesterolemia. (2015) (7)
- The effects of L-carnitine supplementation on glycemic control: a systematic review and meta-analysis of randomized controlled trials (2019) (7)
- Impact of Bariatric Surgery on Pulse Wave Velocity as a Measure of Arterial Stiffness: a Systematic Review and Meta-analysis (2021) (7)
- The Effect of Bariatric Surgery on Circulating Levels of Oxidized Low-Density Lipoproteins Is Apparently Independent of Changes in Body Mass Index: A Systematic Review and Meta-Analysis (2021) (7)
- Metabolic and Anti-inflammatory Response to Melatonin Administration in Patients with Diabetic Nephropathy. (2021) (7)
- Peripheral arterial disease and intermittent claudication in coronary heart disease patients. (2020) (6)
- [A randomized, double-blind, placebo-controlled study of the antilipemic efficacy and tolerability of food supplement policosanol in patients with moderate hypercholesterolemia]. (2005) (6)
- [Arterial hypertension and salt intake]. (2010) (6)
- The effects of L-carnitine supplementation on serum lipids: A systematic review and meta-analysis of randomized controlled trials. (2019) (6)
- Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV Registry. (2019) (6)
- ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). (2011) (6)
- Comment to the position paper on global recommendations for the management of dyslipidemia developed by the International Atherosclerosis Society (IAS). (2014) (6)
- Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022) (2022) (6)
- Statin therapy and sex hormones. (2020) (6)
- [Low HDL-cholesterol--an important risk factor for cardiovascular diseases]. (2011) (6)
- The effects of omega-3 fatty acids supplementation on metabolic status in pregnant women: a systematic review and meta-analysis of randomized controlled trials (2020) (6)
- Risk Assessment and Clinical Management of Children and Adolescents with Heterozygous Familial Hypercholesterolaemia. A Position Paper of the Associations of Preventive Pediatrics of Serbia, Mighty Medic and International Lipid Expert Panel (2021) (6)
- [Croatian guidelines for nutrition in the elderly, part I]. (2011) (6)
- Statins for primary prevention: problems with cardiovascular-risk estimation? (2013) (5)
- ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design. (2018) (5)
- Can we further optimize statin therapy to increase tolerability? (2019) (5)
- Changes in Butyrylcholinesterase Activity and Serum Lipids after Oxprenolol and Glibenclamide Treatments in Non-diabetic Rats (2006) (5)
- Impact of Intravenous Trehalose Administration in Patients with Niemann–Pick Disease Types A and B (2022) (5)
- Effect of simvastatin on micropulmonary red cell mass in patients with hyperlipoproteinemia. (2001) (5)
- The european society of cardiology and the european atherosclerosis society (ESC/EAS) guidelines on the management of dyslipidemia (2011) (5)
- Spontaneous perforation of the small intestine, a novel manifestation of classical homocystinuria in an adult with new cystathionine beta-synthetase gene mutations. (2011) (5)
- The importance of smoking cessation in patients with coronary heart disease. (2018) (5)
- [The effects of plant sterols on hypercholesterolemia]. (2007) (4)
- [Effect of erythropoietin therapy on serum lipoprotein levels in patients on hemodialysis]. (2002) (4)
- The Effects of Statin Therapy on Oxidized LDL and Its Antibodies: A Systematic Review and Meta-Analysis (2022) (4)
- Salt mapping in Croatian. Croatian action on salt and health (CRASH) (2009) (4)
- Haptoglobin genotype 2-2 associated with atherosclerosis in patients with ischemic stroke. (2020) (4)
- A pilot Croatian survey of risk factor (CRO-SURF) management in patients with cardiovascular disease. (2012) (4)
- [European practice guidelines on prevention of cardiovascular diseases: executive summary]. (2008) (4)
- Acute pancreatitis after ocrelizumab treatment for relapsing remitting multiple sclerosis. (2020) (4)
- The Yin and Yang of High-density Lipoprotein and Atherosclerotic Cardiovascular Disease: Focusing on Functionality and Cholesterol Efflux to Reframe the HDL Hypothesis. (2021) (4)
- Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu (2022) (4)
- The time is now: Achieving FH paediatric screening across Europe – The Prague Declaration (2022) (4)
- Effects of Statins on Renin–Angiotensin System (2021) (4)
- Why might visit-to visit variability of lipoproteins have an effect on cardiovascular events? (2020) (4)
- Treatment of children with heterozygous familial hypercholesterolemia. (2019) (4)
- Statins in heart failure - a failure? (2008) (4)
- Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A Position Paper of the International Lipid Expert Panel. (2022) (4)
- Uloga prehrane u prevenciji i terapiji kardiovaskularnih bolesti The Role of Nutrition in the Prevention and Treatment of Cardiovascular Diseases (2009) (3)
- New Therapeutic Approaches in Treatment of Dyslipidaemia—A Narrative Review (2022) (3)
- Influence of erythropoietin treatment on dialyzer reuse. (1997) (3)
- Plasma cortisol in men--relationship with atherosclerosis of retinal arteries. (2002) (3)
- The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients (2021) (3)
- SMMP1 Euroaspire III Survey in General Practice. Lifestyle, Risk Factor and Therapeutic Management in People at High Risk of Developing Cardiovascular Disease from 12 European Regions (2009) (3)
- Association Between Plasma Triglycerides and HDL-Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes: A Global Case-Control Study in 13 Countries (2013) (3)
- Polypill is not a ‘vaccine-like’ solution for primary cardiovascular disease prevention in all parts of the world (2013) (3)
- Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score (2018) (3)
- Plasminogen polymorphism in swine. (1989) (3)
- Effect of green cardamom on lipoproteins, glycemic control and anthropometric parameters: A meta-analysis of randomized clinical trials. (2020) (3)
- Cellular and Molecular Aspects of Managing Familial Hypercholesterolemia: Recent and Emerging Therapeutic Approaches. (2022) (3)
- Prevention of cardiovascular disease guided by total risk estimations - challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy. (2012) (3)
- A view at the future--a dynamical, protocol-based and computationally intensive approach in cardiovascular risk assessment. (2010) (3)
- The Effect of Bariatric Surgery on Circulating Levels of Lipoprotein (a): A Meta-analysis (2022) (3)
- [Croatian guidelines for nutrition in the elderly, part II--clinical nutrition]. (2011) (3)
- Manje soli – više zdravlja. Hrvatska inicijativa za smanjenje nosa kuhinjske soli (CRASH) (2010) (3)
- [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis]. (2002) (3)
- Effect of Bariatric Surgery on Intima Media Thickness: A Systematic Review and Meta-Analysis (2022) (3)
- Comorbidities and Syndemics in the COVID-19 Age: Challenges and Opportunities for Bringing Separated Branches of Medicine Closer to Each Other. (2021) (3)
- Combination therapy with prescription omega-3-acid ethyl esters and statin improves non-HDL-C more effectively than statin alone (2010) (3)
- Plasma lipids, lipoprotein Lp(a), apolipoproteins, and hemostatic risk factors distributions in postmenopausal women. (1999) (3)
- Protective effect of Bridelia tomentosa due to its phenolic acids and flavonoids against oxidative stress-mediated hepatic toxicity induced by carbofuran (2021) (3)
- Is lipoprotein(A) a risk factor for atherosclerosis of the retinal arteries? (2002) (3)
- [Estrogens and risks for onset of atherosclerosis]. (2001) (2)
- [The effects of androgens and other sex hormones on serum lipoproteins]. (1996) (2)
- Are anti-inflammatory agents and nutraceuticals - novel inhibitors of PCSK9? (2020) (2)
- [Characteristics of hyperhomocysteinemia in dialysis patients]. (2006) (2)
- Practical guidelines for diagnosing arterial hypertension of the Croatian Society of Hypertension of Croatian Medical Association and the Working Group on Hypertension of the Croatian Cardiac Society. (2017) (2)
- Digoxin and Outcomes in Patients with Heart Failure and Preserved Ejection Fraction [HFpEF] Patients: A Systematic Review and Meta-analysis. (2022) (2)
- Praktične smjernice za postavljanje dijagnoze arterijske hipertenzije Hrvatskog društva za arterijsku hipertenziju Hrvatskoga liječničkog zbora i Radne skupine za arterijsku hipertenziju Hrvatskoga kardiološkog društva. (2017) (2)
- In silico interactions of statins with cell death-inducing DNA fragmentation factor-like effector A (CIDEA). (2021) (2)
- Impact of Treating Dyslipidemia on Cardiovascular Events (2011) (2)
- [Is hypertriglyceridaemia a risk factor for coronary heart disease?]. (2012) (2)
- Drugo izvješće i evaluacija rizičnih čimbenika u općoj populaciji Hrvatske (2002) (2)
- Promjena načina života - ključni čimbenik u liječenju hiperlipidemija (2001) (2)
- Pathophysiology and Classification of Cardiovascular Diseases Caused by Atherosclerosis (2003) (2)
- [Should we begin with statin therapy in acute coronary syndrome?]. (2004) (2)
- Triglyceride-poor very low density lipoprotein in human serum. (1979) (1)
- Rizični čimbenici hrvatskog pučanstva (2003) (1)
- Effect of statin therapy on plasma apolipoprotein C-III concentrations: a Systematic Review and Meta-Analysis of Randomized Controlled Trials (2018) (1)
- [Pathophysiology of atherosclerosis. II. Etiopathogenic mechanisms and risk factors]. (1990) (1)
- Može li određivanje Lp-PLA(2) pomoći u predviđanju ateroskleroze i kardiocerebrovaskularnih bolesti? (2011) (1)
- [Salt--hidden poison in everyday meal]. (2009) (1)
- Važnost intenzivnog snižavanja LDL kolesterola – uloga "jačih" statina (2012) (1)
- EFFECTS OF PPARγ, APOE, ACE AND AT1R GENE VARIANTS ON DEVELOPMENT OF METABOLIC SYNDROME (2011) (1)
- Effect of statins on abdominal aortic aneurysm. (2022) (1)
- Abnormal systolic blood pressure during treadmill test and brachial artery flow-mediated vasodilatation impairment. (2007) (1)
- Protective Effects of Natural Products and Their Derivatives on Genetic Material: A Critical Review (2021) (1)
- Differential Expression of miRNA-223 in Coronary In-Stent Restenosis (2022) (1)
- The Effects of Statin Treatment on Serum Ferritin Levels: A Systematic Review and Meta-Analysis (2022) (1)
- Što se može poduzeti na razini pučanstva da se smanji rizik za kardiovaskularne bolesti (2012) (1)
- European guidelines regarding the prevention of cardiovascular disease in clinical practice: a shorter version (2008) (1)
- An increase in micropulmonary red cell mass in hyperlipidaemic patients. (1995) (1)
- Is there any association between plasma lipid profile and severity of COVID-19? (2022) (1)
- A Modified Physical Disability Screening Model after Treatment in the Intensive Care Unit: A Nationwide Derivation-Validation Study (2022) (1)
- Koliko hrvatski liječnici i opće pučanstvo znaju o čimbenicima rizika za kardiovaskularne bolesti (2011) (1)
- At a glance: economic impact of industry-sponsored clinical trials of pharmaceutical products (2020) (1)
- 2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy (2022) (1)
- The association between lipid-lowering drugs and circulating concentration of PCSK9 (2019) (1)
- [Guidelines for diagnostics and treatment of arterial hypertension. Practical recommendations of the Croatian Working Group for Hypertension. Consideration on the ESH-ESC 2007 guidelines]. (2008) (1)
- Arterial Stiffness—What Do We Know about It and What Do We Expect from This Biomarker? (2022) (1)
- Ateroskleroza – bolest od koje umire svaki drugi Hrvat (2012) (1)
- PP.29.03: HIGH PREVALENCE OF METABOLIC SYNDROME IN RURAL PART OF CROATIA. CROATIAN RURAL STUDY (2015) (1)
- Association Between Plasma Triglycerides and HDL-Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes : A Global Case-Control Study in 13 Countries Running title : (2013) (1)
- Salt intake and metabolic syndrome. Croatian action on salt and health (CRASH) (2011) (1)
- [Lipids and cardiovascular diseases]. (1990) (1)
- Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer (2020) (1)
- Gaucherova bolest- smjernice za dijagnozu i liječenje odraslih bolesnika (2014) (1)
- Correction: Genistein as a regulator of signaling pathways and microRNAs in different types of cancers (2022) (1)
- An update on regional variation in cardiovascular mortality within Europe (2008) (1)
- The Assessment of Minor Myocardial Damage in the Critically Ill Patients (2006) (1)
- Primarna prevencija arterijske hipertenzije - važnost smanjenja prekomjernog unosa kuhinjske soli (2010) (1)
- Statins block mammalian target of rapamycin pathway: a possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases (2022) (1)
- The effect of nutraceuticals on multiple signaling pathways in cardiac fibrosis injury and repair (2020) (1)
- Changing People’s Habits-Main Factor in the Treatment of Hyperlipidemias (2000) (1)
- Varijabilnost PPARgama je važan čimbenik u razvoju metaboličkog sindroma (2014) (1)
- [Electrocardiographic changes in chronic obstructive lung diseases]. (1982) (1)
- less salt- more health (2014) (1)
- Influence of renal functional mass on the catabolism of endogenous gastrin in humans. (1993) (1)
- Prevencija kardiovaskularnih bolesti u starijih osoba Prevention of Cardiovascular Diseases in the Elderly (2006) (1)
- EUROASPIRE III: lifestyle, risk factor and therapeutic management in people at high risk of developing cardiovascular disease: cross-sectional survey in 12 European countries (2010) (1)
- [Croatian national programme for reduction of excessive salt intake]. (2014) (1)
- How much do Croatian Physicians and Croatian Population Know about Risk Factor for Cadiovascular Diseases (2011) (1)
- Risk factors in Croatian population (2000) (1)
- The Effect of Bariatric Surgery on Circulating Levels of Monocyte Chemoattractant Protein-1: A Systematic Review and Meta-Analysis (2022) (1)
- Učinak liječenja eritropoetinom na konmcentraciju serumskih lipoproteina u hemodijaliziranih bolesnika (2019) (0)
- Monoclonal antibody to human plasma lecithin cholesterol acyltransferase (1985) (0)
- [Levels of growth hormone and prolactin in the blood before, during, and after selective transsphenoidal adenectomy in patients with acromegaly and hypophyseal prolactin-producing tumors]. (1987) (0)
- [Salmonella java infection in children]. (1962) (0)
- Preliminary results of risk factors prevalence in Croatian population (1998) (0)
- 4115Effect of alirocumab on recurrent cardiovascular events after acute coronary syndrome, according to the intensity of background statin treatment (2019) (0)
- HDL-Associated Proteins in Subjects with Polycystic Ovary Syndrome: A Proteomic Study (2023) (0)
- Cardiology in practice in Europe 2012: guidelines (2012) (0)
- Atherosclerosis- The disease that affects every second citizen of Croatia (2007) (0)
- Influence of erythropoietin treatment on serum lipid profile in patients on long-term hemodialysis (2002) (0)
- METABOLIC SYNDROME: EFFECTS OF PPARγ, APOE, LPL, IL-6, ACE AND AT1R GENE VARIANTS (2014) (0)
- Trends of opinion about prevention and treatement of cardiovascular diseases (2007) (0)
- Is there a better future of healthy aging? (2020) (0)
- [Recommendations of Croatian societies on treatment of macrovascular and microvascular complications in patients with metabolic syndrome and diabetes type 2--treatment of residual risk]. (2009) (0)
- The effect of bariatric surgery on circulating levels of lipoprotein(a): a systematic review and meta-analysis (2022) (0)
- [National consensus on hyperandrogenemia]. (1996) (0)
- Effects of whey protein on glycemic control and serum lipoproteins in patients with metabolic syndrome and related conditions: a systematic review and meta-analysis of randomized controlled clinical trials (2020) (0)
- [Comparison of the effects of fenofibrate administered in doses of 3 x 100mg and 1 x 250mg per day in patients with type IIA, IIB and IV hyperlipoproteinemias]. (1988) (0)
- Second report and evaluation of risk factors in Croatian population (1998) (0)
- Obesity and atherosclerosis (2006) (0)
- Variability of PPARgamma is an important factor in the development of the metabolic syndrome (2013) (0)
- Low endogenous progesteron is a risk factor for atherosclerosis of the retinal arteries (2001) (0)
- POSITIVE TRENDS IN AWARENESS OF HARMFUL EFFETCS OF HIGH SALT INTAKE - 10 YEARS CROATIAN ACTION ON SALT AND HEALTH (CRASH). DATA FROM 2008 AND 2017 WORLD HYPERTENSION DAYS (2018) (0)
- CONTINENTAL VERSUS MEDITERRANEAN DIFFERENCES IN RISK FACTORS IN CROATIAN ISCHEMIC HEART DISEASE PATIENTS - TASPIC-CRO V STUDY (2008) (0)
- Molekularna dijagnostika hiperkolesterolemije (2002) (0)
- METABOLIC SYNDROME AND EARLY KIDNEY DAMAGE IN RURAL POPULATION: PP.34.388 (2010) (0)
- New European guidelines on CVD prevention in clinical practice (2007) (0)
- Pseudocholinesterase as an indicator of the degree of insulin resistance and the risk of atherosclerosis (2009) (0)
- [The clinical significance of gastrointestinal hormones (author's transl)]. (1981) (0)
- Produženje radnog vijeka i veća zaposlenost mlađih u korelaciji s aktivnim zdravim starenjem (2011) (0)
- GENDER-SPECIFIC EFFECTS OF PPARG, APOE, ACE, LPL, IL-6 AND AT1R GENE VARIANTS ON METABOLIC SYNDROME (2014) (0)
- Prevalence and management of familial hypercholesterolaemia in the EUROASPIRE IV project (2015) (0)
- Gene variants in young healthy subjects and their effects on biological variables of lipid status and obesity (2008) (0)
- [Pneumonia caused by aspiration of milk]. (1956) (0)
- [Omega-3 fatty acids have proven effects on the heart--the impact of GISSI-HF trial]. (2009) (0)
- Evaluation of risk factors in general population of Croatia (1997) (0)
- The Effects of N-acetylcysteine on Inflammatory Markers and Homocysteine: A Systematic Review and Meta-analysis of Randomized Controlled Trials (2020) (0)
- New trends in laboratory diagnostics: biomarkers of atherosclerosis ; preventive and personalized medicine (2012) (0)
- Pregnancy in Familial Chylomicronemia Syndrome: Plasmapheresis as Therapeutic Approach (2021) (0)
- Određivanje unosa soli u Hrvatskoj. Hrvatski nacionalni porogram za smanjenje unosa kuhinjske soli (2011) (0)
- Healthy lifestile - the responsibility of patients (2005) (0)
- Biosynthesized silver nanoparticles and miR34a mimics mediated activation of death receptor in MCF-7 human breast cancer cell lines (2022) (0)
- Metabolic syndrome and early kidney damage in rural population (2011) (0)
- [Symptomatology and bacteriology of children's diarrhea caused by Escherichia coli]. (1954) (0)
- [POMPE DISEASE - GUIDELINES FOR DIAGNOSIS AND MANAGEMENT OF ADULT PATIENTS]. (2015) (0)
- [Table salt and hypertension--silent killers. Inform yourself and live longer. World day of hypertension 2009 in Croatia]. (2009) (0)
- Genistein as a regulator of signaling pathways and microRNAs in different types of cancers (2021) (0)
- Tu-P7:91 The assessment of minor myocardial damage in the critically ill patients (2006) (0)
- [Sebaceous glands--target organs for androgen hormones]. (1983) (0)
- Guidelines on CVD prevention: confusing or complementary? (2013) (0)
- Metabolic syndrome and dyslipidaemia (2011) (0)
- High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome (2023) (0)
- Dietary management of patients at high risk for cardiovascular disease; EUROASPIRE V (2023) (0)
- Guidelines on diagnosis and conduct of syncope (version 2009) (2009) (0)
- Adiponectin and small LDL-particles (2009) (0)
- The effects of omega-3 fatty acids from flaxseed oil on genetic and metabolic profiles in patients with gestational diabetes mellitus: a randomized, double-blind, placebo-controlled trial – Expression of concern (2021) (0)
- Fish consumption and prevention of atherosclerosis (2006) (0)
- Screening for Familial Hypercholesterolemia Among the Patients with Acute Coronary Syndrome - Pilot Project (2018) (0)
- Nasljedne metaboličke bolesti 2007 ; Bolesti krvnih žila (2008) (0)
- 1.P.132 Hyperlipidemic patients have an increased micropulmonary red cell mass (1997) (0)
- Are endogenous sex hormones important for atherosclerotic cardiovascular disease risk in men? (2022) (0)
- Abstract 11149: Effect of Low-density Lipoprotein Cholesterol Lowering With Alirocumab on Stroke in ODYSSEY OUTCOMES (2019) (0)
- The role of genetic variability in the development of metabolic syndrome (2011) (0)
- patients The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic (2011) (0)
- Policy Paper on Healthy Ageing – BFHA2020 Conference (2020) (0)
- The effects of combined magnesium and zinc supplementation on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease (2020) (0)
- Characteristics of Prehypertension (2012) (0)
- M.620 Low endogenous testosterone is a risk factor for TIA in men (2004) (0)
- Adult pompe disease with late onset cardiomyopathy (2009) (0)
- We-P11:175 APO E and ACE genes in mild essential hypertension (EH) (2008) (0)
- ESR1, LPL and APOE gene variants in relation to lipid status and obesity in young healthy subjects (2010) (0)
- European recommendations for cardiovascular disease prevention in clinical practice (2012 version) (2013) (0)
- [Fabry disease--guidelines for diagnosis and management of adult patients]. (2014) (0)
- Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the international lipid expert panel (ILEP). (2023) (0)
- Scientific opinion on the effect of dietary salt intake reduction (2014) (0)
- Oxidative stress mediated cytogenotoxicological effects of phytol in wistar albino rats (2022) (0)
- Hypothalamo-pituitary-adrenal response to insulin-induced hypoglycemia in subjects with different degrees of obesity. (1986) (0)
- 319 Plasminogen polymorphism in swine (1988) (0)
- [Pathophysiology of atherosclerosis. I. The morphology and developmental levels of atherosclerotic changes]. (1990) (0)
- Primary prevention of arterial hypertension - importance of salt restriction (2010) (0)
- W17-P-015 The influence of risk factors for atherosclerosis to the haemodynamic responses of carotid arteries (2005) (0)
- Adiponectin serum concentrations in dyslipidemic subjects with small dense LDL particles (2009) (0)
- Correction: Genistein as a regulator of signaling pathways and microRNAs in different types of cancers (2022) (0)
- Inherited metabolic diseases 2007 ; Blood vessels diseases (2007) (0)
- [Author reply]. (2014) (0)
- Statins in prevention of heart and brain diseases (2004) (0)
- [Enzyme activities in the erythrocytes of patients with hemolysis (author's transl)]. (1979) (0)
- MicroRNA-mediated regulation of LDL receptor: biological and pharmacological implications. (2023) (0)
- Moderated Poster Session I Epidemiology (2009) (0)
- New trends in classification, monitoring and management of cardiovascular diseases (2002) (0)
- [Less salt--more health: possibilities of prevention in Croatia]. (2010) (0)
- [Gaucher disease--guidelines for diagnosis and management of adult patients]. (2014) (0)
- [Enzyme activities in the erythrocytes of patients with indirect hyperbilirubinemia (author's transl)]. (1978) (0)
- Extracorporeal treatment for refractory hyperlipidemia. (1999) (0)
- 1443Safety of red yeast rice supplementation: a systematic review and meta-analysis of randomized controlled trials (2019) (0)
- Zeljko Reiner With Familial Hypercholesterolemia Impact of Early Evidence of Atherosclerotic Changes on Early Treatment in Children (0)
- T04-P-011 Lipid profile in critically ill patients — An overview of hypocholesterolemia (2005) (0)
- CHARACTERISTICS OF PREHYPERTENSION: PP.19.227 (2010) (0)
- Compendium of Abridged ESC Guidelines 2011 (2012) (0)
- [Differences in the mode of action of antiandrogens and estrogens on the sebaceous glands in man]. (1984) (0)
- Prophylactic therapeutic plasma exchange in pregnant woman with Familial Chylomicronemia Syndrome – A case report (2021) (0)
- Statistical vs clinical significance: A matter of debate for orlistat treatment. (2017) (0)
- Prevention and treatement of atherosclerosis (2007) (0)
- Changes at the population level to promote cardiovascular health (2013) (0)
- ESR, IL-6, LPL and APOE locus variants in young healthy subjects: correlation with lipid status and obesity (2009) (0)
- Guidelines on the identification and treatment of pulmonary hypertension. (2009) (0)
- Citokini i čimbenici rasta određeni biochip array tehnologijom u pacijenata na dijalizi koji boluju od ateroskleroze (2008) (0)
- Polimorfizam ACE gena u bolesnika s koronarnom bolešću starije životne dobi (2019) (0)
- [Management of mucopolysaccharidosis type VI in adults]. (2015) (0)
- LAUREACIJA AMZH - Prof. Ante Dražančić (2009) (0)
- 1.P.364 Effects of gemfibrozil on gas exchange parameters in hypertriglyceridemic patients (1997) (0)
- MS104 THE RELATIONSHIP BETWEEN LEPTIN SERUM CONCENTRATIONS AND PRODUCTION OF SMALL, DENSE LDL PARTICLES (2010) (0)
- CRP as a risk factor for atherosclerosis (2002) (0)
- Possible influence of statins on the paraoxonase activity (2020) (0)
- Effect of statins on the blood lipid profile in patients with different cardiovascular diseases: a systematic review with meta-analysis of randomized clinical trials . (2022) (0)
- Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network. (2023) (0)
- Metabolic Syndrome, Morbidity and Mortlity - in the Era of COVID-19 Pandemic. (2021) (0)
- [Familial hypercholesterolemia - do we think enough about this severe disease?]. (2013) (0)
- Uloga genske varijabilnosti u razvoju metaboličkog sindroma (2011) (0)
- [The correlation between bronchial hypersecretion and auscultatory phenomena in patients with chronic obstructive lung disease]. (1982) (0)
- [Risk factors and carotid atherosclerosis in patients with transient ischaemic attack]. (2004) (0)
- Impact of partnership care model on quality of life in chronic diseases: a systematic review and meta-analysis. (2022) (0)
- Homocystinuria in adult patients (2014) (0)
- Results of the simvastatine on lung's diffusion capacity in hipercholesterolemia patients (1997) (0)
- Association Between Plasma Triglycerides and HDL-Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes: A Global Case-Control Study in 13 Countries Running title: Sacks et al.; Plasma lipids in diabetic microvascular disease (2013) (0)
- Contents Vol. 131, 2015 (2015) (0)
- Nutrigenetika i razvoj metaboličkog sindroma: uloga polimorfizma AT1R (2016) (0)
- The effect of nuts consumption on circulating oxidized low‐density lipoproteins: A systematic review and meta‐analysis of randomized controlled trials (2023) (0)
- Actions to be taken at the level of the population to reduce the risk of cardiovascular diseases (2012) (0)
- New insights into the long non-coding RNAs dependent modulation of heart failure and cardiac hypertrophy: From molecular function to diagnosis and treatment. (2023) (0)
- GuidelinesESC/EAS Guidelines for the Management of Dyslipidaemias (2013) (0)
- Work life extension and higher employment rate of young people in correlation to active healthy aging (2011) (0)
- Chemoprevention of breast carcinoma (1996) (0)
- [Serum lipoproteins: characteristics and metabolism (author's transl)]. (1979) (0)
- Isotachophoresis of human serum lipoproteins. (1984) (0)
- Supresija gonadotropina antiandrogenom terapijom (2005) (0)
- SMJERNICE ZA LIJEČENJE MUKOPOLISAHARIDOZE (MPS) VI U ODRASLIH BOLESNIKA (2015) (0)
- Znanstveni odbor - Redoviti članovi Razreda za medicinske znanosti HAZU (2018) (0)
- Prevencija i liječenje ateroskleroze (2007) (0)
- Je li hipertrigliceridemija čimbenik rizika od koronarne bolesti srca? [Is hypertriglyceridaemia a risk factor for coronary heart disease?]. (2012) (0)
- Aterosklerotične promjene arterija mrežnice odražavaju uznapredovalost ateroskleroze koronarnih arterija (2008) (0)
- Klinički bolnički centar u Domovinskom ratu (2011) (0)
- Povećan unos kuhinjske soli utječe na pojavu karcinoma probavnog sustava (2010) (0)
- Preliminarni rezultati istraživanja rizičnih čimbenika u općoj populaciji Hrvatske (2002) (0)
- Manjak lizosomske kisele lipaze: rijetka nasljedna bolest prerušena u nealkoholnu bolest masne jetre s dislipidemijom (2020) (0)
- Rizični čimbenici za nastanak atheroskleroze (1999) (0)
- Unos soli, metabolički sindrom i pretilost (Hrvatska Nacionalna Kampanja za Smanjenje Unosa Kuhinjske Soli (CRASH)) (2010) (0)
- Tri nove mutacije gena za receptor LDL u hrvatskih bolesnika s porodičnom hiperkolesterolemijom (2014) (0)
- Pseudokolinesteraza kao pokazatelj stupnja inzulinske rezistencije i rizika od razvitka ateroskleroze (2009) (0)
- Što novo donose prve smjernice o liječenju dislipidemija Europskog kardiološkog društva i Europskog društva za aterosklerozu (2011) (0)
- Procjena metaboličkog sindroma kod životno ugroženih bolesnika hospitaliziranih u jedinici intenzivnog liječenja (2005) (0)
- Uloga i mjesto hipolipemika danas (2002) (0)
- [Not Available]. (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Željko Reiner?
Željko Reiner is affiliated with the following schools:
